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ABSTRACT
Hepatosplenic T-cell lymphoma (HSTCL) is a rare non-Hodgkin lymphoma, marked by liver, spleen, and bone marrow 
sinusoidal infiltration, with an aggressive clinical course, which represents a difficult diagnostic task for clinicians and 
pathologists. Another equally severe and challenging condition is the hemophagocytic lymphohistiocytosis (also called 
hemophagocytic syndrome [HS]), which is often associated with hematologic malignancies and infectious diseases. The 
authors report the case of a 56-year-old woman diagnosed with HSTCL based on bone marrow aspirate flow cytometry 
and skin biopsy. The patient underwent a cycle of chemotherapy but the outcome was unfavorable with multiple organ 
failure. The laboratory analysis was consistent with HS. The autopsy confirmed both the remaining lymphoma in the 
pulmonary vessels and the hemophagocytic cells in the spleen and bone marrow.
Keywords 
Lymphoma, T-cell, Peripheral; Lymphohistiocytosis, Hemophagocytic; Autopsy.
CASE REPORT
A 56-year-old woman sought medical care because 
of intermittent fever. Cervical lymphadenomegaly, 
hepatosplenomegaly, lower l imbs edema, and 
hyperchromic skin lesions that were diffusely scattered 
characterized her physical examination.
Laboratory work-up showed pancytopenia 
(hemoglobin = 7.7 g/dL (reference value [RV]: 12-16 
g/dL); 970 leukocytes/mm3 (RV: 4,000-11,000 
leukocytes/mm3); 170 neutrophils/mm3 (RV: 1,600-
7,000 neutrophils/mm3) and 14,000 platelets/mm3 (RV: 
140,000-450,000 platelets/mm3); and mild elevation 
of hepatic enzymes (aspartate aminotransferase 101 
U/L (RV < 31 U/L) and alanine aminotransferase 108 
U/L (RV < 31 U/L).
The patient was hospitalized with the diagnosis 
of febrile neutropenia and treated with piperacillin/
tazobactan.
The myelogram showed the presence of moderate-
to-large cells, with a moderate nucleus/cytoplasm 
ratio, dense chromatin, with some evident nucleolar 
shadows, and abundant, grayish, agranular cytoplasm 
but with some vacuoles. The flow cytometry showed 
positivity for CD45, CD3, CD57, and T-cell receptor 
(TCR) gamma-delta (γδ), and negativity for CD20, 
CD56, CD2, CD4, CD8, CD56, CD14, CD33, and 
CD25, which was consistent with the diagnosis of 
peripheral T-cell lymphoma, gamma-delta type. A skin 
biopsy revealed lymphomatous/leukemic infiltration 
with immunohistochemical positivity for CD3, CD57 
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(Figure 1), Ki-67 (60%), and negativity for CD45 and 
CD20.
The bone marrow biopsy showed hypercellularity 
due to lymphoid cell sinusoidal infiltration with a 
similar immunohistochemical pattern observed in the 
skin (Figure 2).
Such findings, added to the clinical features, 
permitted the diagnosis of hepatosplenic T-cell 
l ymphoma. Chemotherapy was started with 
doxorubicin, vincristine, cyclophosphamide, etoposide, 
and dexamethasone.
The outcome was unfavorable with renal failure 
(creatinine 1.3 mg/dL (RV: 0.5-0.9 mg/dL), enlarged 
prothrombin time (INR 3.09; RV: 0.95-1.2), fibrinogen 
60 mg/dL (RV: 150-200 mg/dL), while ferritin and 
triglyceride determinations raised to 7225 ng/mL 
Figure 1. Photomicrography of the skin. A and B – Dermal infiltration by monomorphic cells (H&E, 100X in A and 
200X in B); C and D – Immunohistochemical positivity for CD3 (C) and CD57 (D), consistent with the diagnosis of 
hepatosplenic T-cell lymphoma.
Figure 2. Photomicrography of the bone marrow. A – Hypercellularity.; B – Neoplastic sinusoidal infiltration with 
immunohistochemical positivity for CD57.
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(RV: 13-150 ng/mL) and 387 mg/dL (RV < 150 mg/
dL), respectively. The hypothesis of hemophagocytic 
syndrome (HS) was raised and corticosteroid pulse 
therapy was started. The patient was referred to 
the intensive care unit but died on the ninth day of 
hospitalization. An autopsy was performed.
AUTOPSY FINDINGS
The patient weighed 58.8 kg and measured 1.62 m. 
The ectoscopy revealed the presence of petechiae and 
bruising in the right flank and periorbitary region, 
with no trauma signs. Hematomas were present at the 
vein puncture sites in the cervical and groin regions. 
Lymphadenomegaly and remaining skin lesions weren’t 
identified.
At the thoracic and abdominal cavities opening, 
500 mL of citrine effusion was drained from each 
cavity. The right lung weighed 524 g and the left 
lung 688 g (RV: 400-800 g), both exhibited a rubbery 
consistency and exhibited friability in some scattered 
areas. Hemorrhage and alveolar edema associated with 
fibrinous exudate and vascular neoplastic leukostasis 
(Figure 3A and 3B) were present (immunohistochemical 
positivity for CD3 and CD57) (Figure 3C and 3D). The 
heart weighed 298 g (RV: 350 g) exhibiting normal 
chamber size and thickness.
The liver weighed 2064 g (RV: 1400-1600 g) 
and had a smooth external surface. The cutting 
surface exhibited a lobular pattern and congestion. 
On microscopy, chronic hepatitis with nodular 
transformation was present, but no remaining 
neoplastic infiltration was found (Figure 4).
The spleen weighed 578 g (RV: 150 g) and showed 
a firm consistency and a winy color. On microscopy, 
hemophagocytosis was evident, as well as a marked 
white pulp depletion and congestion of the red pulp, 
but neoplastic infiltration was absent (Figure 5).
The kidneys weighed 200 g (left) and 206 g 
(right) (RV: 250g each). Their cutting surface was pale 
and the corticomedullary limit was well defined. On 
Figure 3. Photomicrography of the lung. A – Edema, diffuse congestion, and hemorrhage (H&E, 50X); B – Leukostasis 
in pulmonary vessel (H&E, 200X); C – Immunohistochemistry positivity for CD57; D – Immunohistochemistry positivity 
for CD3.
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microscopy, nephrosclerosis and acute tubular necrosis 
were present.
The bone marrow showed a marked cellular 
depletion, edema, and gelatinous degeneration as well 
as hemophagocytosis. Sinusoidal neoplastic infiltration 
was absent (Figure 6).
With the autopsy findings, we conclude that the 
cause of death was HS associated with pulmonary 
Figure 4. Photomicrography of the liver. A – Chronic hepatitis in a nodular transformation (H&E, 50X); B – Portal 
triad detail showing an inflammatory infiltration; lymphoma cells were absent (H& E, 100X).
Figure 5. Photomicrography of the spleen. A – Parenchymal congestion and white pulp depletion (H&E, 50X); 
B – Hemophagocytosis (arrow) observed in the red pulp (H&E, 400X).
Figure 6. Photomicrography of the bone marrow. A – Marked cellular depletion, edema, gelatinous degeneration, 
and multiple histiocytes with hemophagocytosis (H&E, 100X); B – Detail of histiocytes phagocyting red cells (arrows) 
(H&E, 400X).
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damage (edema and hemorrhage) secondary to HSTCL 
under treatment.
DISCUSSION
HSTCL is a type of systemic extranodal lymphoma 
that originates from cytotoxic T-cells, generally with γδ 
T-cell receptors, which characteristically infiltrates the 
liver, spleen, and bone marrow.1 This lymphoma is rare 
and accounts for less than 1% of the non-Hodgkin 
lymphomas, involving most commonly men at the 
mean age of 35 years (ranging from 15 to 65 years).2
Th i s  neop las ia  i s  o f ten assoc ia ted wi th 
immunosuppression (20% of cases) notedly in 
post-transplant patients.2 Current studies and case 
reports also show the relationship of HSTCL with the 
immunosuppression induced during the treatment of 
inflammatory intestinal diseases with the use of purine.2,3 
HSTCL is also related to the Epstein-Barr virus (EBV) 
infection, indicating that this virus could chronically 
stimulates the T-cell, somehow differentiating it from 
the post-transplant lymphoproliferative disease.2
The clinical features are characterized by fever, 
weight loss, fatigue, and hepatosplenomegaly without 
marked peripheral lymphadenopathy.1 Laboratory 
work-up reveals elevation of lactic dehydrogenase and 
hepatic enzymes accompanied by mild abnormalities 
of liver function tests.2 The peripheral blood frequently 
shows a decreased platelet count, which may be due 
to neoplastic bone marrow infiltration, hypersplenism,2 
or HS, when present.
Diagnosis is generally done via the bone marrow 
study, whether by myelogram or by the bone marrow 
biopsy, both of which are accompanied by the 
immunophenotypic study. Eventually, a liver or spleen 
histological study may be required. The neoplastic cells 
are morphologically of medium size with light pink 
cytoplasm showing a sinusoidal pattern of infiltration.1 
Immunophenotype shows positivity for natural killer 
markers such as CD56, CD57, and CD16,1 as well as 
a variable positivity for CD3 (which differentiates it 
from the skin lymphomas).2 The flow cytometry may 
also help to evaluate the γδ T receptors. However, the 
expression of alpha-beta receptors may be present in 
the minority of cases, generally among women under 
the age of 50.1,2
The presence of T-lymphocytes with γδ receptors 
among the innate immune cells of the skin makes it 
a likely site for the HSTCL development. However, 
cutaneous involvement in hepatosplenic γδ T-cell 
lymphoma is not as common as it might be expected, 
in large case series. Yeung et al.4 reported, in 2012, 
a case of a 59-year-old male patient, who presented 
cutaneous lymphomatous infiltration after the 
diagnosis of HSTCL.
In the case reported herein, after the diagnosis of 
lymphoma, the HS ensued. Similarly rare, this entity is of 
challenging diagnosis. Characteristically, this syndrome 
reflects an overreacted systemic inflammation causing 
fever, coagulopathy, hepatomegaly, jaundice, and 
pancytopenia. Among children this syndrome may 
be triggered by a viral infection or may be related to 
genetic abnormalities.5,6 However, in adults, the main 
triggering event is represented by lymphoproliferative 
disorders and sometimes is the first presentation.3,7,8 
The diagnosis is based on clinical and laboratory data 
(Table 1). Immunosupression is the treatment of choice.
The pathophysiology of HS is still not fully 
understood. However, it is believed that there is an 
overstimulation of the immune system, accompanied 
by oversecretion of cytokines, notedly tumor necrosis 
factor-alpha. In this setting, macrophages release 
ferritin, increase plasmin activity (leading to fibrinolysis, 
hepatomegaly, raised serum liver enzymes and 
bilirubin) and inhibit lipoprotein lipase (leading to 
hypertriglyceridemia).9,10 This immune hyperactivity is 
postulated to be secondary to an increase in NK cell 
Table 1. Hemophagocytic lymphohistiocytosis diag-
nostic criteria (adapted from Côté-Daigneault et al.)4
Major criteria (all five should be present)
Fever
Splenomegaly
Bicytopenia or pancytopenia
Hypertriglyceridemia and/or hypofibrinogenemia
Hemophagocytosis in bone marrow biopsy
Minor criteria (the A criteria or the concomitance 
of B and C replace the major criteria)
A: Low or absent NK-cell activity
B: Ferritin > 500 mg/L
C: Soluble CD25 (i.e. soluble IL-2 receptor) ≥ 2,400 U/mL
NK = natural killer.
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activity in response to EBV infection. A very similar 
phenomenon takes place in EBV-related lymphomas.6,10
Therefore, the concurrence of pathogenic factors 
for both HSTCL and HS is observed, explaining some 
reports where the lymphoma and the HS ensue 
concomitantly.3,7,8 Both lymphoma and the HS present a 
poor prognosis. HSTCL usually has aggressive behavior 
and premature therapeutic resistance.
Differently from the cases already reported, the 
diagnosis of HS of this case was based on the autopsy 
findings. Similarly, remaining neoplasia was solely 
represent by leukostasis in the pulmonary vessels, 
infrequently described.
CONCLUSION
HSTL is a rare entity accompanied by a very 
poor prognosis, especially when associated with 
hemophagocytic syndrome, which is hardly diagnosed 
and may present similar physiopatogeny, especially the 
overstimulation of the immune system.
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